Fig. 5From: 1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasisBody weight of BALB/c mice bearing 4T1 tumors, treated with a 1-MNA and cyclophosphamide (CP) or b 1,4-DMP and cyclophosphamide (CP), both presented with relevant controls. In Fig. 5a-b, days of the drug administrations are indicated with arrows (1-MNA or 1,4-DMP- solid arrow, cyclophosphamide – gray arrows). Data are presented as mean values ± SDBack to article page